| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TBX3 VAX1 ZNF143 FOXK2 GPER1 ZNF607 NEUROD4 BACH1 GATA2 SREBF2 HLX ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 HOXA3 ZNF263 ZNF526 DMRT3 HOXD3 NFIA GLI2 ZBTB40 SP9 TSHZ1 ZNF281 | 4.89e-05 | 1412 | 177 | 28 | GO:0000981 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 7.81e-05 | 2 | 177 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 7.81e-05 | 2 | 177 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX3 VAX1 ZNF143 FOXK2 ZNF607 NEUROD4 BACH1 GATA2 SREBF2 CHD7 ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 HOXA3 ZNF263 ZNF526 DMRT3 HOXD3 NFIA GLI2 SP9 ZNF281 | 1.05e-04 | 1244 | 177 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX3 VAX1 ZNF143 FOXK2 ZNF607 NEUROD4 BACH1 GATA2 SREBF2 CHD7 ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 HOXA3 ZNF263 ZNF526 DMRT3 HOXD3 NFIA GLI2 SP9 ZNF281 | 1.47e-04 | 1271 | 177 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.83e-04 | 13 | 177 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 2.33e-04 | 3 | 177 | 2 | GO:0008454 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TBX3 ZNF143 FOXK2 BACH1 GATA2 ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 HOXD3 NFIA GLI2 | 4.85e-04 | 560 | 177 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TBX3 ZNF143 FOXK2 BACH1 GATA2 ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 HOXD3 NFIA GLI2 | 5.38e-04 | 566 | 177 | 14 | GO:0001216 |
| GeneOntologyBiologicalProcess | ear development | TBX3 GATA2 CDH23 CHD7 SHROOM2 TFAP2A ZIC3 DCANP1 CCM2 USH1G GLI2 DCHS1 TSHZ1 SLITRK6 USH2A | 2.81e-08 | 285 | 178 | 15 | GO:0043583 |
| GeneOntologyBiologicalProcess | ear morphogenesis | TBX3 GATA2 CDH23 CHD7 TFAP2A ZIC3 DCANP1 USH1G GLI2 TSHZ1 SLITRK6 | 1.00e-07 | 154 | 178 | 11 | GO:0042471 |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.83e-06 | 129 | 178 | 9 | GO:0042472 | |
| GeneOntologyBiologicalProcess | embryonic organ development | A2M TPO TBX3 GATA2 HLX CDH23 CHD7 SYF2 BIRC6 TFAP2A ZIC3 HOXA3 DCANP1 HOXD3 USH1G GLI2 TSHZ1 SLITRK6 | 1.86e-06 | 561 | 178 | 18 | GO:0048568 |
| GeneOntologyBiologicalProcess | inner ear development | TBX3 GATA2 CDH23 CHD7 TFAP2A DCANP1 CCM2 USH1G GLI2 DCHS1 SLITRK6 USH2A | 2.14e-06 | 253 | 178 | 12 | GO:0048839 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | TBX3 GATA2 HLX CDH23 CHD7 TFAP2A ZIC3 HOXA3 DCANP1 HOXD3 USH1G GLI2 TSHZ1 SLITRK6 | 2.32e-06 | 351 | 178 | 14 | GO:0048562 |
| GeneOntologyBiologicalProcess | cochlea development | 1.42e-05 | 61 | 178 | 6 | GO:0090102 | |
| GeneOntologyBiologicalProcess | sensory organ development | TBX3 VAX1 NEUROD4 SIPA1L3 GATA2 CDH23 CHD7 SHROOM2 TFAP2A ZIC3 DCANP1 CCM2 NFIA USH1G GLI2 DCHS1 TSHZ1 SLITRK6 USH2A | 1.90e-05 | 730 | 178 | 19 | GO:0007423 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TBX3 ZNF143 FOXK2 GPER1 NEUROD4 NACA BACH1 GATA2 SREBF2 AKNA WWTR1 CHD7 ZNF226 MLXIP PRDM4 TFAP2A ZIC3 MEOX2 ZNF263 PPARGC1B TNFSF11 HOXD3 NFIA ATXN7 GLI2 FIZ1 DOT1L MED26 | 2.32e-05 | 1390 | 178 | 28 | GO:0045944 |
| GeneOntologyBiologicalProcess | cranial nerve development | 2.45e-05 | 67 | 178 | 6 | GO:0021545 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TBX3 POC1A NACA GATA2 HLX CDH23 WWTR1 CHD7 SHROOM2 TFAP2A ZIC3 HOXA3 PPARGC1B DCANP1 TNFSF11 DMRT3 HOXD3 EDAR USH1G GLI2 DCHS1 TSHZ1 SEMA6A SLITRK6 USH2A WDR72 | 3.54e-05 | 1269 | 178 | 26 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | A2M TPO TBX3 GATA2 HLX CDH23 CHD7 CUBN SYF2 ZP3 BIRC6 INO80D TFAP2A ZIC3 MEOX2 HOXA3 DCANP1 CCM2 HOXD3 USH1G GLI2 KIAA1217 PGAP1 DCHS1 SP9 TSHZ1 SLITRK6 ZNF281 | 4.19e-05 | 1437 | 178 | 28 | GO:0009790 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | TBX3 GATA2 CDH23 CHD7 SHROOM2 TFAP2A ZIC3 DCANP1 USH1G GLI2 TSHZ1 SLITRK6 | 4.53e-05 | 343 | 178 | 12 | GO:0090596 |
| GeneOntologyBiologicalProcess | semicircular canal development | 9.91e-05 | 11 | 178 | 3 | GO:0060872 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 1.38e-04 | 91 | 178 | 6 | GO:0009880 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TBX3 GATA2 HLX CDH23 CHD7 SYF2 TFAP2A ZIC3 HOXA3 DCANP1 HOXD3 USH1G GLI2 SP9 TSHZ1 SLITRK6 ZNF281 | 1.54e-04 | 713 | 178 | 17 | GO:0048598 |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 1.60e-04 | 32 | 178 | 4 | GO:0021602 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 2.14e-04 | 14 | 178 | 3 | GO:0021514 | |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 2.21e-04 | 3 | 178 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | specification of animal organ position | 2.21e-04 | 3 | 178 | 2 | GO:0010159 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 2.86e-04 | 104 | 178 | 6 | GO:0060021 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 3.05e-04 | 247 | 178 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | nerve development | 3.69e-04 | 109 | 178 | 6 | GO:0021675 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 7.09e-05 | 10 | 179 | 3 | GO:0031080 | |
| MousePheno | abnormal secondary palate morphology | 4.12e-05 | 159 | 145 | 9 | MP:0013550 | |
| MousePheno | abnormal face shape | 5.79e-05 | 21 | 145 | 4 | MP:0030071 | |
| MousePheno | abnormal fibrous joint morphology | 8.07e-05 | 135 | 145 | 8 | MP:0030878 | |
| MousePheno | abnormal circulating alanine level | 8.77e-05 | 9 | 145 | 3 | MP:0030672 | |
| MousePheno | abnormal urine progesterone level | 1.07e-04 | 2 | 145 | 2 | MP:0011545 | |
| MousePheno | short soft palate | 1.07e-04 | 2 | 145 | 2 | MP:0030291 | |
| MousePheno | abnormal urine deoxycorticosterone level | 1.07e-04 | 2 | 145 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 1.07e-04 | 2 | 145 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 1.07e-04 | 2 | 145 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 1.07e-04 | 2 | 145 | 2 | MP:0011546 | |
| MousePheno | small forehead | 1.07e-04 | 2 | 145 | 2 | MP:0030043 | |
| MousePheno | abnormal neurocranium morphology | VAX1 CHD7 TFAP2A ZIC3 TNFSF11 HOXD3 GLI2 PGAP1 TSHZ1 MN1 HYDIN | 1.13e-04 | 269 | 145 | 11 | MP:0000074 |
| MousePheno | abnormal craniofacial development | TBX3 VAX1 CHD7 TFAP2A ZIC3 HOXA3 CCM2 TNFSF11 EDAR GLI2 PGAP1 TSHZ1 MN1 WDR72 | 1.35e-04 | 425 | 145 | 14 | MP:0003935 |
| MousePheno | abnormal alanine level | 1.70e-04 | 11 | 145 | 3 | MP:0031638 | |
| MousePheno | abnormal palatal shelf fusion at midline | 1.80e-04 | 80 | 145 | 6 | MP:0009887 | |
| Domain | Cyt_P450_mitochondrial | 8.63e-05 | 2 | 174 | 2 | IPR002399 | |
| Domain | GSCR1_dom | 8.63e-05 | 2 | 174 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 8.63e-05 | 2 | 174 | 2 | PF15249 | |
| Domain | SOHO | 2.57e-04 | 3 | 174 | 2 | PS50831 | |
| Domain | DUF4074 | 2.57e-04 | 3 | 174 | 2 | IPR025281 | |
| Domain | RBR | 2.57e-04 | 3 | 174 | 2 | PF17208 | |
| Domain | DUF4074 | 2.57e-04 | 3 | 174 | 2 | PF13293 | |
| Domain | Sorb | 2.57e-04 | 3 | 174 | 2 | SM00459 | |
| Domain | SCML2_RBR | 2.57e-04 | 3 | 174 | 2 | IPR033763 | |
| Domain | Sorb | 2.57e-04 | 3 | 174 | 2 | PF02208 | |
| Domain | SoHo_dom | 2.57e-04 | 3 | 174 | 2 | IPR003127 | |
| Domain | - | DCAF1 NWD1 POC1A WDR46 NUP43 NUP214 BIRC6 EML5 WDR45B SEMA6A WDR72 | 2.99e-04 | 333 | 174 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 NWD1 POC1A WDR46 NUP43 NUP214 BIRC6 EML5 WDR45B SEMA6A WDR72 | 3.14e-04 | 335 | 174 | 11 | IPR015943 |
| Domain | Glyco_transf_54 | 5.11e-04 | 4 | 174 | 2 | IPR006759 | |
| Domain | Glyco_transf_54 | 5.11e-04 | 4 | 174 | 2 | PF04666 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.80e-04 | 32 | 126 | 4 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.04e-04 | 33 | 126 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.29e-04 | 34 | 126 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.57e-04 | 35 | 126 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.87e-04 | 36 | 126 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.87e-04 | 36 | 126 | 4 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 3.20e-04 | 37 | 126 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 3.20e-04 | 37 | 126 | 4 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.93e-04 | 39 | 126 | 4 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.33e-04 | 40 | 126 | 4 | MM14945 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 4.77e-04 | 41 | 126 | 4 | M29574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.77e-04 | 41 | 126 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.24e-04 | 42 | 126 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.73e-04 | 43 | 126 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.73e-04 | 43 | 126 | 4 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 6.26e-04 | 44 | 126 | 4 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.43e-04 | 46 | 126 | 4 | M27397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 7.79e-04 | 5 | 126 | 2 | M47522 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.06e-04 | 47 | 126 | 4 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.06e-04 | 47 | 126 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 9.45e-04 | 49 | 126 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.02e-03 | 50 | 126 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.10e-03 | 51 | 126 | 4 | MM15151 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX3 VAX1 ZNF143 FOXK2 NEUROD4 BACH1 GATA2 SREBF2 AKNA HLX KIAA1549 MLXIP PRDM4 TFAP2A MEOX2 HOXA3 DMRT3 HOXD3 ZFP36L2 NFIA GLI2 SP9 TSHZ1 ZNF281 | 6.87e-11 | 908 | 180 | 24 | 19274049 |
| Pubmed | ZNF143 FOXK2 NUP107 ZNF607 RPN2 BICRA UBR4 NACA FBRS GATA2 NUP98 CHD7 NUP214 SPATA2 UBN2 ATXN1L INO80D ZIC3 NFIA ATXN7 GLI2 XRN1 ZBTB40 SP9 DOT1L ZNF281 GARRE1 | 6.32e-09 | 1429 | 180 | 27 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TBX3 FOXK2 BICRA FBRS NUP98 NUP43 CHD7 NUP214 UBN2 ATXN1L ZNF263 NFIA ZNF281 | 4.27e-08 | 351 | 180 | 13 | 38297188 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 MGAT4B FOXK2 SH3RF1 BICRA SIPA1L3 UBR4 FBRS GATA2 AKNA MIB2 NUP214 MLXIP TTC3 BIRC6 TBC1D17 PCNX2 ZNF263 ZFP36L2 KANK3 SORBS3 DOT1L | 7.43e-08 | 1105 | 180 | 22 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXK2 BICRA CARMIL1 SIPA1L3 PCDH11Y SREBF2 MSH5 RBBP8NL UBN2 TTC3 SHROOM2 ZP3 PCNX2 RANBP17 ERGIC1 PPARGC1B NFIA ATXN7 GLI2 KIAA1217 EEPD1 MAST1 WDR45B SEMA6A IMMP2L | 2.31e-07 | 1489 | 180 | 25 | 28611215 |
| Pubmed | UBR4 PCDH11Y AKNA PRDM4 SHROOM2 PCNX2 ATXN7 PDE4DIP MAST1 TNS3 | 4.24e-07 | 233 | 180 | 10 | 37704626 | |
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 5.43e-07 | 4 | 180 | 3 | 15377787 | |
| Pubmed | 7.49e-07 | 191 | 180 | 9 | 24146773 | ||
| Pubmed | TBX3 FOXK2 SH3RF1 NEUROD4 BACH1 GATA2 SREBF2 ZNF226 PRDM4 BIRC6 TFAP2A MEOX2 HOXD3 NFIA GLI2 RNF180 | 9.96e-07 | 709 | 180 | 16 | 22988430 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | TBX3 VAX1 GATA2 SREBF2 PRDM4 TFAP2A ZIC3 MEOX2 ZNF263 DMRT3 HOXD3 GLI2 SP9 ZNF281 | 1.06e-06 | 544 | 180 | 14 | 28473536 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TBX3 FOXK2 NUP107 RPN2 BACH1 GATA2 NUP98 NUP43 WWTR1 CHD7 NUP214 MLXIP SYF2 UBN2 INO80D TFAP2A SCML2 NFIA ANAPC1 FIZ1 SF3A3 ZNF281 | 1.07e-06 | 1294 | 180 | 22 | 30804502 |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 30580687 | ||
| Pubmed | NUP107 UBR4 FBRS CHD7 NUP214 RBBP8NL BIRC6 MSTO1 CCDC88A ANAPC1 FIZ1 XRN1 | 2.10e-06 | 418 | 180 | 12 | 34709266 | |
| Pubmed | 4.70e-06 | 7 | 180 | 3 | 20058854 | ||
| Pubmed | The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis. | 4.70e-06 | 7 | 180 | 3 | 19362612 | |
| Pubmed | DCAF1 NID2 TBX3 NUP107 BICRA FBRS KIAA1549 INO80D ZNF526 EML5 ACAD11 ANAPC1 ATXN7 FIZ1 XRN1 BICRAL ZNF281 GARRE1 WDR72 | 5.97e-06 | 1116 | 180 | 19 | 31753913 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 7.49e-06 | 8 | 180 | 3 | 19683999 | |
| Pubmed | 7.49e-06 | 8 | 180 | 3 | 18484607 | ||
| Pubmed | 7.49e-06 | 8 | 180 | 3 | 16545802 | ||
| Pubmed | 8.06e-06 | 25 | 180 | 4 | 10601273 | ||
| Pubmed | 9.49e-06 | 26 | 180 | 4 | 12228227 | ||
| Pubmed | Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 subcomplex. | 1.12e-05 | 9 | 180 | 3 | 17360435 | |
| Pubmed | PDE4B FOXK2 POC1A FBRS SREBF2 CHD7 MSH5 CUBN UBN2 TTC3 SHROOM2 ATXN1L SCML2 EML5 PGAP1 ZBTB40 DOT1L CCDC171 | 1.48e-05 | 1084 | 180 | 18 | 11544199 | |
| Pubmed | 1.52e-05 | 152 | 180 | 7 | 38360978 | ||
| Pubmed | 1.52e-05 | 152 | 180 | 7 | 34299191 | ||
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 1.59e-05 | 10 | 180 | 3 | 24618850 | |
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 24239741 | ||
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 15146057 | ||
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 20676042 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23150505 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 2.66e-05 | 2 | 180 | 2 | 21164264 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8645611 | ||
| Pubmed | Direct interaction of the Usher syndrome 1G protein SANS and myomegalin in the retina. | 2.66e-05 | 2 | 180 | 2 | 21767579 | |
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 2.66e-05 | 2 | 180 | 2 | 12231255 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17006639 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12786748 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20634641 | ||
| Pubmed | TorsinA is essential for neuronal nuclear pore complex localization and maturation. | 2.66e-05 | 2 | 180 | 2 | 39117796 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1303253 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 21875659 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1741400 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 32540969 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 26047574 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 26324851 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7669222 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22933298 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 2.66e-05 | 2 | 180 | 2 | 2256920 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 2.66e-05 | 2 | 180 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 2.66e-05 | 2 | 180 | 2 | 16396990 | |
| Pubmed | Vinexin family (SORBS) proteins regulate mechanotransduction in mesenchymal stem cells. | 2.66e-05 | 2 | 180 | 2 | 30068914 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 2.66e-05 | 2 | 180 | 2 | 18397978 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1518866 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11259252 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 2.66e-05 | 2 | 180 | 2 | 2592361 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23314847 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 2.66e-05 | 2 | 180 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 2.66e-05 | 2 | 180 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 2.66e-05 | 2 | 180 | 2 | 15731365 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12575948 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17360538 | ||
| Pubmed | Maintenance of functional equivalence during paralogous Hox gene evolution. | 2.66e-05 | 2 | 180 | 2 | 10688203 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23892081 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17651452 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9166401 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 34743356 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 2.66e-05 | 2 | 180 | 2 | 20339375 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11371513 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20808686 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20015870 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 31208857 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 2.66e-05 | 2 | 180 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 2.66e-05 | 2 | 180 | 2 | 21625068 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16110193 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 26066897 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10698202 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18651133 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22083159 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8167223 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 2.66e-05 | 2 | 180 | 2 | 15699546 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18162527 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 38341019 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 26936824 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24837548 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 2.66e-05 | 2 | 180 | 2 | 19820005 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16434023 | ||
| Pubmed | A locus on distal chromosome 10 (ahl4) affecting age-related hearing loss in A/J mice. | 2.66e-05 | 2 | 180 | 2 | 18280008 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 2.66e-05 | 2 | 180 | 2 | 15062555 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17075030 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17075029 | ||
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 2.66e-05 | 2 | 180 | 2 | 15507509 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8710855 | ||
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 2.66e-05 | 2 | 180 | 2 | 17296872 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 2.66e-05 | 2 | 180 | 2 | 18039983 | |
| Interaction | POU5F1 interactions | DCAF1 NID2 ZNF143 RPN2 UBR4 NACA BACH1 MUC16 CHD7 CUBN SYF2 UBN2 TFAP2A ZIC3 SCML2 GLI2 SF3A3 ZNF281 | 3.52e-06 | 584 | 175 | 18 | int:POU5F1 |
| GeneFamily | Nucleoporins | 5.04e-05 | 32 | 116 | 4 | 1051 | |
| GeneFamily | Cytochrome P450 family 11 | 1.22e-04 | 3 | 116 | 2 | 1007 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF143 ZNF607 ZNF226 PRDM4 ZIC3 ZNF263 ZNF526 GLI2 FIZ1 ZBTB40 SP9 TSHZ1 ZNF281 | 7.00e-04 | 718 | 116 | 13 | 28 |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 1.43e-03 | 9 | 116 | 2 | 435 | |
| GeneFamily | WD repeat domain containing | 1.51e-03 | 262 | 116 | 7 | 362 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | THSD4 TPO TBX3 GATA2 SORBS1 PLA2G4C KIAA1217 EEPD1 KANK3 SEMA6A | 5.83e-09 | 190 | 180 | 10 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | THSD4 TPO TBX3 GATA2 SORBS1 PLA2G4C KIAA1217 EEPD1 KANK3 SEMA6A | 6.13e-09 | 191 | 180 | 10 | f229abf69a1217194f74b0502486907e07dba989 |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.59e-08 | 181 | 180 | 9 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 6.74e-08 | 185 | 180 | 9 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-08 | 189 | 180 | 9 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-08 | 189 | 180 | 9 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | TBX3 GATA2 SORBS1 SHROOM2 PLA2G4C KIAA1217 EEPD1 KANK3 SEMA6A | 8.47e-08 | 190 | 180 | 9 | 0a351609a72fd638c84b2435782e312ee6a33aac |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 9.26e-08 | 192 | 180 | 9 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.10e-07 | 196 | 180 | 9 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | THSD4 TBX3 GATA2 SORBS1 SHROOM2 PLA2G4C KIAA1217 KANK3 SEMA6A | 1.10e-07 | 196 | 180 | 9 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.10e-07 | 196 | 180 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | SH3RF1 PDK4 MGAT4A GATA2 KIAA1549 SORBS1 PPARGC1B CD14 KIAA1217 | 1.15e-07 | 197 | 180 | 9 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-07 | 198 | 180 | 9 | 2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc | |
| ToppCell | distal-Endothelial-Capillary-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | A2M PDE4B GPER1 GATA2 KIAA1549 SORBS1 PPARGC1B KIAA1217 KANK3 | 1.31e-07 | 200 | 180 | 9 | ab96d3d801373459a2503ccfb665dc3f43bfb5a1 |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-07 | 200 | 180 | 9 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-07 | 169 | 180 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-07 | 182 | 180 | 8 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.01e-06 | 188 | 180 | 8 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 1.01e-06 | 188 | 180 | 8 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-06 | 189 | 180 | 8 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 193 | 180 | 8 | ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 193 | 180 | 8 | 7401e276b644b254c692160d0e7417ec28d50aa4 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.23e-06 | 193 | 180 | 8 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 194 | 180 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 194 | 180 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-06 | 194 | 180 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-06 | 194 | 180 | 8 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 194 | 180 | 8 | e30a3765feae5cd10ddba16a166c31eb5717edd3 | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-06 | 194 | 180 | 8 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 195 | 180 | 8 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.33e-06 | 195 | 180 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-06 | 195 | 180 | 8 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 195 | 180 | 8 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-06 | 197 | 180 | 8 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 197 | 180 | 8 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 198 | 180 | 8 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-06 | 199 | 180 | 8 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.55e-06 | 199 | 180 | 8 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-06 | 199 | 180 | 8 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 200 | 180 | 8 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 200 | 180 | 8 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 200 | 180 | 8 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 200 | 180 | 8 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-06 | 200 | 180 | 8 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.29e-06 | 94 | 180 | 6 | 9664f74bc0168c92fb8a68cad628323c476f6103 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.29e-06 | 94 | 180 | 6 | c73e99890431750b74f984de5c82e33533ab708b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.29e-06 | 94 | 180 | 6 | 1bda61101f45f5c4a68453087b880fdc6d9acfca | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 5.39e-06 | 167 | 180 | 7 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.06e-06 | 170 | 180 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 6.30e-06 | 171 | 180 | 7 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-06 | 172 | 180 | 7 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 174 | 180 | 7 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-06 | 177 | 180 | 7 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-06 | 178 | 180 | 7 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.18e-06 | 178 | 180 | 7 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 8.80e-06 | 180 | 180 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 8.80e-06 | 180 | 180 | 7 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-06 | 183 | 180 | 7 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 180 | 7 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 187 | 180 | 7 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 187 | 180 | 7 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.13e-05 | 187 | 180 | 7 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.21e-05 | 189 | 180 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.21e-05 | 189 | 180 | 7 | fcfb28bd96471affc13e55aa7228f594aaa967cd | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.21e-05 | 189 | 180 | 7 | f515a04ae1746257d4568cea13a3dd75b4b05275 | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-05 | 190 | 180 | 7 | 347c7bf67ade235a4e2320db6a75ce0dab8744f9 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 1.25e-05 | 190 | 180 | 7 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 190 | 180 | 7 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.25e-05 | 190 | 180 | 7 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-05 | 190 | 180 | 7 | 0c7da05fbd3f095dde7550585209c056f0b76990 | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.29e-05 | 191 | 180 | 7 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 191 | 180 | 7 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 191 | 180 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 191 | 180 | 7 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 1.29e-05 | 191 | 180 | 7 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 191 | 180 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-05 | 191 | 180 | 7 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.29e-05 | 191 | 180 | 7 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.29e-05 | 191 | 180 | 7 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 192 | 180 | 7 | dfa6adc776621f4b51d731b796c0421855b2297c | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 192 | 180 | 7 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 180 | 7 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 180 | 7 | e7805e866339f676e3f770980c2e0a649eff472e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 193 | 180 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-05 | 193 | 180 | 7 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.38e-05 | 193 | 180 | 7 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-05 | 193 | 180 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-05 | 193 | 180 | 7 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 193 | 180 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 193 | 180 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | facs-Heart-RA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 180 | 7 | 1ad941098f1a44a46c2f6ebff32a98ada32c80ab | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-05 | 193 | 180 | 7 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 180 | 7 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 180 | 7 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 194 | 180 | 7 | 12496bc964d1c572241410524a89ca1a9fdb7e34 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 194 | 180 | 7 | f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 1.43e-05 | 194 | 180 | 7 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | DCAF1 ABCC3 GPER1 BICRA SIPA1L3 FBRS HLX CHD7 SORBS1 PDE4DIP SORBS3 MN1 | 4.62e-08 | 196 | 177 | 12 | 7071_UP |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 2.94e-05 | 11 | 169 | 3 | EFO_0801461 | |
| Disease | Glucocorticoid-remediable aldosteronism | 3.26e-05 | 2 | 169 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 3.26e-05 | 2 | 169 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 9.75e-05 | 3 | 169 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | trypanosomiasis (biomarker_via_orthology) | 1.94e-04 | 4 | 169 | 2 | DOID:10113 (biomarker_via_orthology) | |
| Disease | ADP-ribosylation factor-like protein 11 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801355 | |
| Disease | hearing impairment | 2.57e-04 | 98 | 169 | 5 | C1384666 | |
| Disease | Usher syndrome, type 1A | 3.22e-04 | 5 | 169 | 2 | C2931205 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 3.22e-04 | 5 | 169 | 2 | DOID:446 (is_implicated_in) | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 3.22e-04 | 5 | 169 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 3.22e-04 | 5 | 169 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 3.22e-04 | 5 | 169 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 3.22e-04 | 5 | 169 | 2 | cv:C1568247 | |
| Disease | pulse pressure measurement | THSD4 LYPLAL1 CYP11B2 CARMIL1 GATA2 MSH5 RRAS HOXA3 HOXD3 ATXN7 KIAA1217 EEPD1 ATAD2B SF3A3 DOT1L FER1L5 GARRE1 HYDIN TNS3 | 4.13e-04 | 1392 | 169 | 19 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | NID2 TBX3 GPER1 UBR4 NUP98 SREBF2 BCHE SORBS1 NUP214 CUBN TTC3 SHROOM2 TFAP2A HOXA3 PPARGC1B ZNF281 | 4.74e-04 | 1074 | 169 | 16 | C0006142 |
| Disease | Conn Syndrome | 4.82e-04 | 6 | 169 | 2 | C1384514 | |
| Disease | Usher Syndrome, Type I | 4.82e-04 | 6 | 169 | 2 | C1568247 | |
| Disease | Hyperaldosteronism | 4.82e-04 | 6 | 169 | 2 | C0020428 | |
| Disease | glutamate measurement | 6.04e-04 | 29 | 169 | 3 | EFO_0010487 | |
| Disease | Hereditary retinal dystrophy | 6.72e-04 | 7 | 169 | 2 | C0154860 | |
| Disease | Usher syndrome | 6.72e-04 | 7 | 169 | 2 | cv:C0271097 | |
| Disease | protocadherin alpha-7 measurement | 6.72e-04 | 7 | 169 | 2 | EFO_0801973 | |
| Disease | myocarditis (biomarker_via_orthology) | 6.72e-04 | 7 | 169 | 2 | DOID:820 (biomarker_via_orthology) | |
| Disease | Acute Myeloid Leukemia, M1 | 7.83e-04 | 125 | 169 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 7.83e-04 | 125 | 169 | 5 | C1879321 | |
| Disease | protein FAM163B measurement | 1.14e-03 | 9 | 169 | 2 | EFO_0802936 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.15e-03 | 447 | 169 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | skin pigmentation measurement | 1.18e-03 | 137 | 169 | 5 | EFO_0007009 | |
| Disease | adseverin measurement | 1.42e-03 | 10 | 169 | 2 | EFO_0801358 | |
| Disease | androstenedione measurement | 1.42e-03 | 10 | 169 | 2 | EFO_0007972 | |
| Disease | C-reactive protein measurement | PDE4B CARMIL1 HLX MIB2 CHD7 ZNF226 RANBP17 TNFSF11 EEPD1 RAVER2 ZBTB40 KCNN3 SP9 SLITRK6 CCDC171 WDR72 | 1.60e-03 | 1206 | 169 | 16 | EFO_0004458 |
| Disease | photoreceptor cell layer thickness measurement | 1.66e-03 | 148 | 169 | 5 | EFO_0803370 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.67e-03 | 88 | 169 | 4 | EFO_0803332 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.73e-03 | 11 | 169 | 2 | EFO_0021862 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.73e-03 | 11 | 169 | 2 | EFO_0004810, GO_0050896 | |
| Disease | eye color | 1.81e-03 | 90 | 169 | 4 | EFO_0003949 | |
| Disease | myeloid leukemia (is_implicated_in) | 2.44e-03 | 13 | 169 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | colorectal cancer | 2.63e-03 | 604 | 169 | 10 | MONDO_0005575 | |
| Disease | age-related hearing impairment | 2.74e-03 | 324 | 169 | 7 | EFO_0005782 | |
| Disease | testosterone measurement | PDE4B CYP11B1 CYP11B2 AKNA DAO CHD7 CSMD3 DCT BIRC6 NFIA ANAPC1 IL1R2 PGAP1 USH2A TNS3 WDR72 | 2.78e-03 | 1275 | 169 | 16 | EFO_0004908 |
| Disease | biliary atresia (is_marker_for) | 2.84e-03 | 14 | 169 | 2 | DOID:13608 (is_marker_for) | |
| Disease | suntan | 2.96e-03 | 103 | 169 | 4 | EFO_0004279 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.11e-03 | 171 | 169 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | tumor necrosis factor beta measurement | 3.26e-03 | 15 | 169 | 2 | EFO_0008308 | |
| Disease | Leukemia, Myelocytic, Acute | 3.27e-03 | 173 | 169 | 5 | C0023467 | |
| Disease | cup-to-disc ratio measurement | 3.47e-03 | 430 | 169 | 8 | EFO_0006939 | |
| Disease | lower face morphology measurement | 3.62e-03 | 109 | 169 | 4 | EFO_0010948 | |
| Disease | neutrophil collagenase measurement | 3.71e-03 | 16 | 169 | 2 | EFO_0008248 | |
| Disease | Ciliopathies | 3.74e-03 | 110 | 169 | 4 | C4277690 | |
| Disease | coffee consumption measurement | 4.05e-03 | 182 | 169 | 5 | EFO_0006781 | |
| Disease | hip bone mineral density, hip bone size | 4.10e-03 | 56 | 169 | 3 | EFO_0004844, EFO_0007702 | |
| Disease | Acute myeloid leukemia | 4.19e-03 | 17 | 169 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.19e-03 | 17 | 169 | 2 | 601626 | |
| Disease | sweet liking measurement | 4.70e-03 | 18 | 169 | 2 | EFO_0010156 | |
| Disease | glucuronate measurement | 4.70e-03 | 18 | 169 | 2 | EFO_0010486 | |
| Disease | creatine kinase measurement | 4.74e-03 | 59 | 169 | 3 | EFO_0004534 | |
| Disease | FEV/FEC ratio | THSD4 NID2 LYPLAL1 HLX CDH23 BCHE WWTR1 ERGIC1 PPARGC1B FCGBP HOXD3 ANAPC1 KCNN3 CCDC171 MN1 | 4.81e-03 | 1228 | 169 | 15 | EFO_0004713 |
| Disease | response to cranial radiation therapy, short-term memory | 4.97e-03 | 60 | 169 | 3 | EFO_0004335, EFO_0010950 | |
| Disease | Juvenile Myelomonocytic Leukemia | 5.23e-03 | 19 | 169 | 2 | C0349639 | |
| Disease | femoral neck bone mineral density | 5.53e-03 | 196 | 169 | 5 | EFO_0007785 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSHLPYSQATLHGTA | 196 | Q495M9 | |
| FTVHTVSPGNSHLAL | 141 | Q8TF63 | |
| HNSSIDPHGLYSLSL | 311 | O14867 | |
| SVSLHLLSPGSHSLF | 231 | P06276 | |
| TASSFLPHFQALHVV | 11 | P49703 | |
| SLLHASNGHSVPAVL | 2036 | Q9NR09 | |
| SNGHSVPAVLQSTFH | 2041 | Q9NR09 | |
| FTGAEVPSHLTSNSH | 791 | Q7Z407 | |
| LSPTHADSLHTSFNI | 1751 | Q8IZF6 | |
| FINTVPHALTSSHSS | 1296 | Q6TFL3 | |
| SLPHVTSNHVSYNGL | 656 | Q9UK96 | |
| LTHFNLISHGFGSPA | 376 | P05549 | |
| ISSLAHHLSTAAFNG | 386 | Q9Y2Z9 | |
| SASAPYLTNHLGHTL | 4331 | Q86UQ4 | |
| TFAHTPALASLGLSN | 141 | P35858 | |
| RAIFDGASTPTHHLS | 231 | Q9BSQ5 | |
| SICQAHFFHLPSGSE | 2906 | Q96M86 | |
| LSLHSFSDGASLPHK | 1326 | Q8TEK3 | |
| VGNNSHHFIISPTSV | 391 | Q9H251 | |
| GFASLQPSLHHPSTN | 46 | Q9P2D1 | |
| STALHGESVAHSPRF | 261 | Q9P2D1 | |
| PSKNHSDGHRLASFA | 416 | Q7L9B9 | |
| HHPVSSITGQDFSAS | 1366 | O94823 | |
| STIGHPLSDLAHFSL | 246 | Q709F0 | |
| SFSPSQSLPASHAHL | 571 | P01023 | |
| PLHLAATHGHSFTLQ | 101 | Q8N9B4 | |
| ASSTGCVTVFLHHPN | 91 | Q8NFH3 | |
| LHFFATSHPALVGQL | 816 | Q149M9 | |
| PSQTSSLGTAFTQHH | 336 | Q12857 | |
| HFPFLGISDNHSLSD | 646 | Q9H2T7 | |
| SFPNLAAGSLLVGHH | 531 | Q9HCJ3 | |
| SNSFGPVSLGLLHAH | 131 | Q96T52 | |
| FSHHDLAPALDTGTT | 651 | P57740 | |
| LSHLHTFVSSQPAGL | 1401 | O15438 | |
| LSHVHSPNAENLGLF | 76 | P14920 | |
| TASHAALAFSRTHSP | 346 | Q9HCM3 | |
| ISSISPGLHSFTDHQ | 351 | Q9NPC2 | |
| HILIFSDSQTGNPSH | 176 | Q16654 | |
| PTAEALHHSLFTAFS | 26 | Q8NG50 | |
| SRAHSPALGVHSFSG | 351 | Q9H1A4 | |
| PSLFQHVGLHSSLSG | 356 | Q9UM21 | |
| TNTPSIHLGAHASSE | 1246 | Q8WXI7 | |
| IHLGAHASSESPSTI | 1251 | Q8WXI7 | |
| DHAPTFGSAHLSLEV | 1746 | Q96JQ0 | |
| QLHSAAVNGLSFHPS | 226 | Q8NBT0 | |
| TLHGHQGPATTVAFS | 266 | Q8NBT0 | |
| HAAVGASAPSAPTAH | 916 | Q9Y4B6 | |
| SHFTVALQLGIPHSF | 291 | Q9NVH1 | |
| ASTHIASSLGINPHV | 976 | P52948 | |
| ALTAHLGSVHPHASF | 71 | Q14774 | |
| LGSVHPHASFQAAAR | 76 | Q14774 | |
| ALFGLTHLPHAASGA | 381 | O43365 | |
| FKPSLFQHVGTHSSL | 361 | Q9UQ53 | |
| PASPNHAGVLSAHSS | 371 | Q01167 | |
| GSGQTSHLAPALLHT | 776 | Q9ULI0 | |
| SPSANLATSHLPHFV | 161 | P0C7T5 | |
| STLSPFQHAHKELSG | 166 | Q9UNE0 | |
| SRPQSHSSGEFSLLH | 1616 | Q3V6T2 | |
| ITSHHSSGPLELSAQ | 151 | A6NKB5 | |
| NLNDHLLGHSPSSTA | 131 | Q9UGI6 | |
| DFILLGIFNHSPTHT | 11 | Q8NG83 | |
| DFILLGIFNHSPTHT | 11 | A3KFT3 | |
| DFLLLGIFNHSPTHT | 11 | Q8NG81 | |
| LNTAFGLVHLTAHSS | 281 | Q9BUK6 | |
| QASSSAGLVLHATFP | 111 | Q07343 | |
| STAAFRFGHATIHPL | 486 | P07202 | |
| NFHSLDGTSTRAFHP | 796 | Q32MH5 | |
| VPGNFHVSTHSATAQ | 126 | Q969X5 | |
| HAAPFAKSHLVHGSS | 1031 | P35658 | |
| HSSLFSGALSPSLLH | 1521 | P10070 | |
| SPHATAQGLHPFSQS | 11 | P50222 | |
| AQGLHPFSQSSLALH | 16 | P50222 | |
| PFSQSSLALHGRSDH | 21 | P50222 | |
| LGHLSHPSSASVDYS | 376 | P31249 | |
| LLSSSGAQTPGAHHF | 496 | O95402 | |
| SNELPVNSHGSFSHS | 811 | O15265 | |
| VNSHGSFSHSHTPLD | 816 | O15265 | |
| HHFNQTIGSASPSTA | 1021 | Q02413 | |
| HFSTRLHTAATEGLP | 1356 | Q96JM4 | |
| VGSSHTTQSFPAKLH | 1226 | Q9Y2H9 | |
| PFSFHHVLSLTGDAQ | 226 | P26010 | |
| HSSVPLGRSFSHATA | 291 | Q14112 | |
| FSQSQGLVITTHHPA | 501 | Q9HAP2 | |
| TPHHAGFSALGAFVS | 196 | Q9UP65 | |
| QHGSLSPAAAHTASP | 461 | Q8NC74 | |
| TGPFARIHFHSDSQI | 676 | O60494 | |
| TAPQNHTISLFFHSL | 3426 | O60494 | |
| VASLTPTAAHSGSHL | 156 | P23769 | |
| AAGVQPHSLDLSHNS | 246 | P08571 | |
| HPASLFTATGAVHAA | 136 | Q9HAH7 | |
| FGVLQPHSSHQISFT | 1336 | Q4G0P3 | |
| HVGISVPSQHLSNSS | 191 | Q6AI39 | |
| HHVQQGISFASASSP | 336 | Q6AI39 | |
| ALPSNGHIFEHTLSS | 306 | Q9NQL9 | |
| PFQLDSLLHAHLSGA | 2161 | Q9Y6R7 | |
| SAHTSHLVGSALSDP | 271 | O75390 | |
| HHSISLEAASPGLAA | 431 | Q8N3K9 | |
| SHQGSPLVTRHNSAA | 661 | O15063 | |
| TALQHGAHLVPTFTF | 206 | Q58HT5 | |
| LVGHSPSSASLNFLH | 211 | P15538 | |
| SHISTAGTLAQPFAA | 946 | Q7Z591 | |
| SPSFSLLQSAHPGEH | 91 | Q9UEW3 | |
| SAAALASHLEAHSGP | 341 | Q96SL8 | |
| PAGRHSASLIFLHGS | 16 | Q5VWZ2 | |
| AVTGAVLFLNHAHAP | 46 | Q8N539 | |
| SAAFGHQLSSHSGIP | 976 | Q53TQ3 | |
| VHTLAAAQGPSGHLS | 416 | Q8NFN8 | |
| LLHAHLSSGQPDTQS | 781 | Q6NY19 | |
| HSLTPVSSDHLFLFG | 271 | Q9Y2U9 | |
| SFHNAPPLSAITHGT | 11 | Q3LI81 | |
| LASALAHNPNSGLHT | 266 | Q5VZK9 | |
| LVGHSPSSASLNFLH | 211 | P19099 | |
| LGHSPHVTNIRFTSG | 1931 | Q05BV3 | |
| RSVLITTGFPTHFNH | 331 | Q7Z3D6 | |
| APHSGAHSAHILSAA | 531 | Q9NZM4 | |
| AHSAHILSAAPIQVG | 536 | Q9NZM4 | |
| AHFSQDLASHPAGVS | 61 | A0A1B0GTI1 | |
| GSHLGLAASPTHSAI | 31 | Q9UKN5 | |
| GTALHHSPPSAQASA | 1221 | Q9BZA8 | |
| HLSPLDFLHSANFSL | 351 | Q86T96 | |
| DAHSDTPLHSAISAG | 561 | Q96AX9 | |
| GNLPDFHSSGASSHA | 171 | Q10571 | |
| ASHASHTAAQAGLPD | 751 | O43196 | |
| PNTFLNFSHAVSLHL | 76 | Q8IW52 | |
| LHPNAHSNSASFIFG | 116 | O75445 | |
| VTPLAFSVGHHQSTL | 3816 | O75445 | |
| FPTSNSLLHGTHVPS | 161 | O95926 | |
| SGASAATLPFHLQQH | 571 | O15119 | |
| SAAASSSVHRHPFLN | 616 | O15119 | |
| HEDPSGSLHLAATSS | 276 | Q9H5Y7 | |
| PAHSVLFSPAGALHS | 716 | A0AVI2 | |
| AHPLTGHIVNLAAFS | 301 | Q99527 | |
| LSSPLHFVNTHFNGA | 401 | Q8NC44 | |
| SHLRHATAQPASQAG | 666 | Q86YN6 | |
| LLSLDPHFSHDGTSS | 1186 | O60292 | |
| SLTHTGKGHHLSFSP | 1866 | Q5T5P2 | |
| HFSSLGSVDSLDHPS | 171 | Q13796 | |
| SGLTFLPKLSHHTSA | 251 | Q75T13 | |
| SNNSLLAFPGTHTGH | 151 | Q5MNZ6 | |
| LSHNFLTVAPGHSSH | 1066 | Q68CZ2 | |
| ALLFPGSSQARHVNH | 16 | Q08648 | |
| VSAFTLQPAAHTGAA | 11 | P27930 | |
| QSSLHSGAPQASLHS | 201 | P0CG40 | |
| HHFTSPLSGNQEVSA | 106 | Q99470 | |
| LSPASVGLSHHSLAS | 616 | Q7Z6J0 | |
| STSFLSVLNPHGAHA | 16 | Q8TCW9 | |
| QHGLFAGSASSLHAP | 136 | O60481 | |
| VFPHDSSALSNSFHH | 186 | Q9HA65 | |
| SAFPSKASTHDSLAH | 411 | Q9UM82 | |
| PAHDAVISSAGTHSV | 536 | P52747 | |
| AQHAATLSHSPLPAH | 1311 | Q6ZU65 | |
| LFVATLHFPHASNIT | 131 | O14656 | |
| TFAPSTIIFHLGHAA | 571 | P04844 | |
| LLSSQPFSSSRGHTH | 461 | Q9UQR0 | |
| PNSSSRAIHVHQFGD | 106 | P08294 | |
| SFVALNGHSSSLLPS | 571 | Q9H2E6 | |
| HTPSSGIHQDSFLQL | 1081 | Q9BX66 | |
| QHPHSGSGRSVLSFE | 511 | Q12772 | |
| LAVAHSHSSLGQLPS | 116 | Q4KMG9 | |
| FSSGHQLTAPHTFES | 346 | Q96SK3 | |
| HQSVTSLLYPHGLSS | 461 | Q3MJ13 | |
| SGHLGALNHSPQSLF | 1206 | Q8IZH2 | |
| NTTLLHSPGTLHAAA | 126 | Q9Y6L7 | |
| ATEHNSGTSHLPGLL | 481 | Q12815 | |
| NHAALHRDPSVFSAG | 1766 | P53804 | |
| LGHGFQFVSLSSPLH | 686 | Q9Y2X9 | |
| QFVSLSSPLHNHTLF | 691 | Q9Y2X9 | |
| QSSLHITASQPSHAG | 91 | A0A0B4J273 | |
| DFIPGHLQSHIGSSS | 16 | O60504 | |
| LVHSFLNGTNALPHS | 371 | P40126 | |
| STRTLPHGAGHLAFS | 396 | O15213 | |
| FSSPETSRFGHHISQ | 341 | Q6P444 | |
| AHLTINATDIPSGSH | 166 | O14788 | |
| FSRPSSLQAHQGVHT | 456 | Q9NYT6 | |
| GIQFLSSHNLPHGST | 21 | O43615 | |
| TPGEALASSLFFQHH | 41 | Q8TF50 | |
| ALTHAGAHLDLSAFS | 236 | Q12874 | |
| ASSLFHSPETSNNHG | 256 | Q6ZMP0 | |
| QVPRSEASAFGASHH | 151 | P10301 | |
| ALLFPGSSQARHVNH | 16 | Q6PDA7 | |
| SSSGSVSDHLVLHPQ | 1981 | Q5T4S7 | |
| HSASNLHALAHPAPS | 56 | P47974 | |
| RSPTFHLGDAAHLQA | 186 | P21754 | |
| SASTFNHRGSLHPSS | 251 | Q8N228 | |
| PLGSQHVSLSLSVHY | 441 | Q96RL6 | |
| SLSSAEHNALLHSPG | 611 | Q6ZSZ6 | |
| ATFRFPGALQHHVTT | 1111 | Q9NUA8 | |
| GAQHVRSHSSPASLQ | 81 | Q9GZV5 | |
| LHLGHAGSSPHALAS | 61 | P54219 | |
| LHAGAPAAGHSLFSL | 261 | Q5SQQ9 | |
| SDSTPFLTNHGAHKA | 556 | O14978 | |
| HLTQFSPHFKSGSLA | 866 | P35573 | |
| GSHLAPLHQSSFGSV | 306 | E9PAV3 | |
| AHSGFHFHSIPKLAS | 1691 | Q5VU43 | |
| SSLSSGHVHSTPFQA | 286 | Q9HD90 |